Bringing Japanese Know-How to the Global Market: A Visit to Shimadzu Medical Systems
TCROSS NEWS and its global partner, Angioplasty.Org, visited Shimadzu Corporation, a major Japanese company founded in 1875, to learn about its plans for future overseas business development of its angiography systems. We saw demonstrations of the Trinias Angiography System, the SCORE StentView software and more.
Background: Despite increasing availability of primary angiography, in many outer metropolitan and rural health districts in Australia, a vast proportion of patients with ST-elevation myocardial infarction (STEMI) are further than 90 minutes from a percutaneous coronary intervention (PCI) capable site . Therefore thrombolysis remains a reasonable, immediate reperfusion treatment strategy for these patients [1,2].
Background: Many outer-metropolitan and rural hospitals rely on thrombolysis to manage patients with ST-elevation myocardial infarction (STEMI) due to patients being 90 minutes away from percutaneous coronary intervention (PCI) facilities . Current international guidelines recommend coronary angiography occur 2 –24 hours after successful thrombolysis . However, after successful reperfusion following thrombolysis, limited resources may delay angiogram in some patients (>24 hours).
We examined the outcomes of patients with abdominal circumference (AC) ≥100cm in diameter from the Standard Versus Ultrasound-Guided (US) Radial and Femoral Access (SURF) Trial.
This study aimed to investigate left ventricular end diastolic pressure (LVEDP), a surrogate marker for left ventricular dysfunction, as a predictor for LVT formation.
Introduction: Coronary artery disease is common in patients with severe aortic stenosis. As transcatheter aortic valve implantation (TAVI) moves into intermediate risk patients, coronary angiography (CA) and percutaneous coronary intervention (PCI) post TAVI will become increasingly common. Selective coronary re-access has been reported to be particularly challenging with the self-expanding CoreValve.
Background: This pilot study aims to investigate for subclinical endothelial injury following transradial coronary angiography (CA) and percutaneous coronary intervention (PCI)
We present the first multicentre Australian experience on the safety and feasibility of this approach.
Authors: Gurbuz AS, Ozturk S, Efe SC, Yılmaz MF, Yanik RE, Yaman A, Kirma C Abstract Objective: Heparanase (HPA) is an endo-β-D-glucuronidase capable of degrading heparin sulphate (HS) and heparin side chains. HPA plays a role in tumour growth, angiogenesis, cell invasion and in activation of the coagulation system. We aimed to investigate the relationship between HPA and thrombus burden (TB) in patients with ST-Segment Elevation Myocardial Infarction (STEMI). Methods: This prospective study enrolled 187 patients with STEMI who were treated with primary percutaneous coronary intervention (pPCI). Blood samples...
A 62-year-old woman with persistent chronic thromboembolic pulmonary hypertension (CTEPH) status after pulmonary thromboendarterectomy presented with worsening exercise capacity and continued dyspnea requiring 3 L O2 at home. Ventilation perfusion scan (Fig 1) demonstrated A high probability of pulmonary embolism. Pulmonary angiography (Fig 2) revealed multifocal subsegmental arterial occlusions and stenoses consistent with CTEPH. Her medications included macitentan, riociguat, and selexipag for CTEPH.
Authors: Ghorbani A, Yazdankhah S, Adel MH, Tabesh H, Sattari AR, Sattari SA, Heybar H, Madjidi S Abstract INTRODUCTION: Contrast-induced nephropathy (CIN) is a frequent complication of contrast exposure. A recent study suggested that Na/K citrate might have a preventive role. We investigated the efficacy of Na/K citrate to prevent CIN in patients with renal dysfunction undergoing coronary intervention. METHODS: The randomized, double-blind, placebo-controlled trial included 201 patients with estimated creatinine clearance .05). Post-exposure Cr values were not significantly different between the two groups (1....